HomeEventsAAO-HNS/F OTO ForumAAO-HNS/F OTO Forum CME Information

AAO-HNS/F OTO Forum CME Information

The AAO-HNS/F OTO Forum provides an intimate forum for leadership discussions and practice management tools, highlighting the current and future needs of private practice physicians caring for otolaryngologic patients. The program will thematically focus on all things private practice otolaryngology with the guideposts of networking, benchmarking, innovation, and healthcare trends. This program includes didactic and interactive sessions led by peers and subject matter experts in the specialty.

By attending the AAO-HNS/F OTO Forum attendees will be able to:

Analyze key financial benchmarks and data analytics in private practice to assess operational efficiency and identify opportunities for revenue growth and cost reduction.
Evaluate emerging trends in artificial intelligence, technology, and in-office procedures to determine their applicability and potential impact on patient outcomes and practice workflow.
Apply best practices in employee retention, physician-payer relations, and advocacy efforts to enhance practice culture, optimize reimbursement strategies, and improve patient access to care.
Create strategic marketing and reputation management plans tailored to different budget levels to effectively position and grow a private ENT practice.
Demonstrate proficiency in coding, billing, and regulatory compliance by integrating updated payment considerations and value-based care models into practice operations.

Target Audience

The OTO Forum is designed for otolaryngology-head and neck surgery residents, young physicians, and physician members.

Accreditation

This meeting has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. AAO-HNSF is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Claiming CME/MOC Credit

OTO Logic

AAO-HNSF designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Participants should only claim credit commensurate with the extent of their participation. The OTOLogic team will be emailing you a link to complete your evaluation to claim your CME/MOC credit.

Deadline to claim credit is May 27, 2025.

Need assistance? Visit the CME webpage or contact us at [email protected]

The following sessions are approved for CME and will also count for MOC.

Friday, April 25

Benchmarking for Your Ancillaries	0.75
Technology and AI in Private Practice: Updates and Trends	0.75
Beyond Benefits: How a Strong Culture Enhances Employee Retention	0.75
Case Studies in Data Analytics: How do you Measure Up?	1.0
In-Office Surgery 2.0: Pearls and Pitfalls	1.0
Best Practices in Incorporating APPs into Practice	1.0
Two to Tango: How Physician / Payer Relations Impact Policies for Improved Patient Outcomes and Cost Savings	1.0

Saturday, April 26

Welcome ENT-PAC (Legislative Update & Priorities) \| Advocacy in ENT: Why it Matters	1.0
Mastermind Roundtables: Ask the Experts	0.75
Subspecialties in Private Practice	0.75
Strategies for Success in Value-Based Care (VBCs) and MIPS Value Pathways (MVPs) in Private Practice	1.0
Marketing and Reputation Management: Strategies for Different Budgets	0.75
Coding & Billing 2025: Payment Considerations for New Devices and Technologies	0.75
Revenue & Cost Allocation Models: Strategies for Your Business	1.0

This session is not eligible for CME/MOC credit:

Hearing Aid Industry Leaders Panel: Maximizing Best Hearing Healthcare

Presenter Disclosure of Relevant Financial Relationships

The AAO-HNSF is committed to creating high-quality education that is independent of industry influence. All persons who have been in control of this educational content for this accredited CE activity has been asked to disclose all financial relationships with any ineligible companies they have had over the past 24 months.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum threshold; all financial relationships, regardless of amount, with ineligible companies.

The ACCME also requires that AAO-HNSF manage any reported conflict and eliminate the potential for bias during the educational activity. All of the relevant financial relationships listed for these individuals have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Disclosures	Nothing to Disclose	Disclosure
		Company	Role	Received
Planning Committee
Rahul K. Shah, MD, MBA		Csurgeries		Stock or Stock Options
		ScribeBrain AI LLC		Stock Or Stock Options
		SpringerNature		Royalty
		Zoc AI Products		Stock Or Stock Options
		DHVP Fund I, Digital Health Venture		Stock Or Stock Options

Annette M. Pham, MD	X
Taniza Holmes-Craggette	X
Meghan Callahan, CMP	X
Beth Burchill, CMP	X
Elise Emmons, MA	X
Faculty
Jason L. Acevedo, MD, MBA, FAAOA	X
Douglas D. Backous, MD		Grace Medical		Royalty
Douglas D. Backous, MD		Healthy Hearing Ears Initiative		Honoraria
Cristina Baldassari, MD		Nyxoah	Consultant	Consulting Fee
Brad Bichey, MD, MPH		Nemedic, Inc.		Intellectual Property Rights
Eugene G. Brown, III, MD, RPh		Neurent	Consultant	Consulting Fee
G. Lee Bryant, Jr., MD	X
Neal W. Burkhalter, MD	X
Stephen P. Cragle, MD	X
Marc G. Dubin		Stryker	Consultant	Consulting Fee
		Neurent		Consulting Fee
		Medtronic		Consulting Fee
		Integra		Consulting Fee
		Synopsis		Stock or Stock Options
Julie Farley		Auris Practice Solutions, LLC
D. Scott Fortune, MD	X
Drew Franklin	X
Daniel R. Gold, MD	X
David A. Godin, MD
Jennifer L. Goodrich, MD	X
Eli R. Groppo, MD	X
Jedidiah J. Grisel, MD		Amplify Hearing USA		Stock or Stock Options
Willard C. Harrill, MD		BridgepointMD		Stock or Stock Options
Andrew Johnson, MD	X
Srinivas R. Kaza, MD	X
Carlos Lopez	X
Michelle F. Liu, MD, MPH	X
Lance A. Manning, MD	X
Frank G. Opelka,MD		Episodes of Care Solutions	Direct Financial Relationship	Consulting Fee
Nora W. Perkins, MD		Aerin Medical	Consultant	Consulting Fee
Nora W. Perkins, MD		Stryker	Consultant	Consulting Fee
Kelly Phillips, MBA	X
Eileen M. Raynor, MD		Inspire		Research Funding
		Ambu	Consultant	Consulting Fee
		NCMS	President
Douglas D. Reh, MD		NeurEnt	Consultant	Consulting Fee
		Sound Health
		Optinose		Honoraria
Geoff Rosenthal, MD	X
Matthew Scarlett, MD	X
Troy Simonson	X
Elise Swinehart	X
Holly Thompson	X
Andrew J. Tompkins, MD, MBA	X
Camille White	X
Melanie Wilson Seybt, MD	X
Mike Utecht, MD	X
Jeffrey S. Weingarten, MD	X
Kevin Watson	X
David M. Yen, MD		3-D Matrix	Consultant	Consulting Fee
		Aerin Medical		Research Funding
		Astra Zeneca		Research Funding
		AventaMed		Research Funding
		Capital Blue Cross		Research Funding
		Cyrano Therapeutics		Stock or Stock Options
		DiagNose Medical		Stock or Stock Options
		GSK		Research Funding
		Lyra Therapeutics		Research Funding
		Medtronic		Consulting Fee
		Neubio North America	Consultant	Consulting Fee
		Neurent Medical
		OptiNose		Consulting Fee
		Oyster Point Pharmaceutical	Consultant	Research Funding
		Pocket Naloxone
		Regeneron		Consulting Fee
		Sanofi		Research Funding
		Spirair	Consultant	Honoraria
		Stryker		Honoraria
		Eli Lilly		Research Funding
		Tympanogen		Consulting Fee
		Evidera		Research Funding
			Consultant	Research Funding
				Research Funding
Justin Wyrick	X
Dianne Williams	X

Clinical Medicine Recommendations/Scientific Research Reporting

The AAO-HNS informs all presenters and expects that:

All recommendations involving clinical medicine in a professional education activity must be based on evidence that is accepted within the profession of medicine as adequate justification for the indications and contradictions in the care of patients; and
All scientific research referred to, reported, or used in professional education in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Free Exchange of Medical Education Statement

AAO-HNSF is committed to the free exchange of medical education. Inclusion of any presentation or exhibit in this activity, including presentations or exhibits on drugs or medical devices, or the uses of drugs or medical devices that have not been approved by the FDA, does not imply an endorsement by the AAO-HNSF of the uses, products, or techniques presented.

The information contained in this activity represents the views of those who created it and does not necessarily represent the official view or recommendations of AAO-HNSF.

Deadline to claim credit is May 27, 2025.

Need assistance? Visit the CME webpage or contact us at [email protected]